Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands.
about
An update on the management of urinary tract infections in the era of antimicrobial resistance.Antimicrobial resistance surveillance in urinary tract infections in primary care.Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections.Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections.The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric studyHigh prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran.Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in U.S. Medical Centers, 2012 to 2014.Antibiotics Clinical Development and Pipeline.Pharmacokinetics of intravenous finafloxacin in healthy volunteers.Risk factors that influence the empirical treatment of patients with acute pyelonephritis: a cohort study.National laboratory-based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the Netherlands.
P2860
Q30244815-C6B540C4-65C4-4311-A752-DB0EEE14E68AQ30249261-EBF42136-D0AE-497E-A031-77AA0E8D49A0Q33617939-47D077D9-4040-4EF7-932B-B0265D47637BQ36204123-ACF28635-F8FD-4DFC-9F4A-11E65FE9D4A8Q36356590-D9EE4A56-2DA1-4361-8FD7-F8E278DBA0EEQ36657434-A6038EFC-6AC2-41BA-ADA5-06BBB437796FQ37023324-1072BC6B-190E-49D9-96FF-622F15ED3D47Q38544966-B0655BC6-4472-4072-BD7F-CE03E6948BDAQ38636236-AB5619F0-A526-49B8-9BF2-2565FFAEC2A5Q41991746-EAD15AC0-5739-4789-929D-822A35C55DDEQ47103632-BD7A400F-2FE1-4491-B667-A7D112B53FCD
P2860
Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Recommendations for the empiri ...... resistance in the Netherlands.
@ast
Recommendations for the empiri ...... resistance in the Netherlands.
@en
type
label
Recommendations for the empiri ...... resistance in the Netherlands.
@ast
Recommendations for the empiri ...... resistance in the Netherlands.
@en
prefLabel
Recommendations for the empiri ...... resistance in the Netherlands.
@ast
Recommendations for the empiri ...... resistance in the Netherlands.
@en
P2093
P2860
P1433
P1476
Recommendations for the empiri ...... resistance in the Netherlands
@en
P2093
Akke K van der Bij
ISIS-AR Study Group
Jan Muilwijk
Jos C Monen
Maike Koningstein
Maurine A Leverstein-van Hall
Sabine C de Greeff
Suzanne E Geerlings
P2860
P304
P356
10.1371/JOURNAL.PONE.0086634
P407
P577
2014-01-28T00:00:00Z